ACT Lung Health Intervention: Phase Two

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorDana-Farber Cancer Institute

About this trial

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Eligibility criteria

Qualifiers

Self-identify as either Chinese or Korean

Speak either Korean, Mandarin, or English

Are 18 years of age or older

Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days)

Disqualifiers

Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.

Adults unable to consent.

Adults younger than 50 or older than 80 years

Individuals who are not yet adults (infants, children, teenagers)

Trial design

Treatments tested in this trial

  • ACT Lung Health Intervention

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Dana-Farber Cancer Institute

Lead sponsor

National Cancer Institute (NCI)

Collaborator

University of Massachusetts, Boston

Collaborator